Legacy Wealth Partners (California)’s Regeneron Pharmaceuticals REGN Stock Holding History

Legacy Wealth Partners (California)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.07M	Buy	+1,916	New	+$971K	0.59%	46

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Legacy Wealth Partners (California)'s REGN Position: Q2 2021 in Review

Legacy Wealth Partners (California) opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2021: 1,916 shares worth $1.07M. The stake represents 0.59% of the portfolio and ranks #46 among its holdings.

971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

Legacy Wealth Partners (California) held 1,916 shares of Regeneron Pharmaceuticals worth $1.07M as of Q2 2021.
Regeneron Pharmaceuticals was a new Legacy Wealth Partners (California) position in Q2 2021.
Regeneron Pharmaceuticals made up 0.59% of Legacy Wealth Partners (California)'s portfolio in Q2 2021, its #46 holding.
971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on Legacy Wealth Partners (California)'s 13F filing for Q2 2021, filed 16 Aug 2021.